The Quebec-based biopharmaceutical firm that produced a COVID-19 vaccine is being shut down by parent company Mitsubishi Chemical.
Mitsubishi Chemical said it had been preparing to commercially produce the Covifenz vaccine but decided against doing so because of the “significant changes” in theThe company said it would dissolve Medicago because it is no longer “viable” to continue marketing its products.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:
Is this the Quebec facility under construction during the pandemic justie was boasting about?